NovaSparks Gets New Backer in MBO Deal, Eyes Options Data & FPGA Trading Capabilities

With the support of new majority owner Peninsular Capital, NovaSparks plans initiatives to expand the use cases for its FPGA market data technologies into the trading and risk sectors.


NovaSparks has completed a management buy-out (MBO) from its former private equity owner, and found a new backer to help accelerate its expansion, while growing employees’ stake in the company.

The move gives French asset manager Peninsular Capital control of 51% of NovaSparks, which specializes in field-programmable gate array (FPGA) ticker plant and feed handler appliances. Additionally, existing management and staff will double their stake from around 20% to just over 45%. Michaël Lévy, a 30

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

If you already have an account, please sign in here.

Brown Brothers Harriman unifies busy suite of AI products

It’s a new world, contend BBH’s Kevin Welch and Josh Fine. After a few years of experimentation that yielded several AI products for the bank and its clients, it was time to put the puzzle pieces together to serve a different way of working post-Covid.

Bank-backed Versana takes aim at syndicated loan tech

Born from a consortium that includes JP Morgan and Bank of America, Versana aims to bring up-to-date and permissioned data to the syndicated loan market—the first step to a more transparent and faster operating market.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: